Skip to main content
. 2020 Sep 15;12:383–389. doi: 10.2147/RRU.S267417

Table 3.

Bladder capacity According to Treatment Response

Variable CR (%) PR (%) NR (%) Total (%) p value
Patient number 15 (21.7) 30 (43.5) 24 (34.8) 69 (100)
EBC 265.8±45.0 283.5±62.3 250.5±50.3 268.2±56.1 0.049
FBC
In chart 172.3±62.6 158.4±81.6 133.3±69.8 152.6±74.6 0.201
In UFM 155.0±60.1 144.9±70.7 127.3±57.7 141.3±64.2 0.279
FBC/EBC
FBC in chart/EBC 62.1±16.5 54.6±22.5 53.2±22.1 55.6±21.2 0.309
FBC in UFM/EBC 59.8±23.8 51.1±20.5 49.5±16.7 52.6±20.3 0.421
Lower FBC/EBC ratio
FBC in chart/EBC 10 (66.7) 23 (76.7) 14 (58.3) 47 (68.1) 0.461
FBC in UFM/EBC 8 (53.3) 22 (73.3) 18 (75.0) 48 (69.6) 0.19

Notes: Values are presented as mean±standard deviation or number (%) for categorical variables. p-values were calculated using Kruskal–Wallis tests.

Abbreviations: CR, complete response; PR, partial response; NR, no response; EBC, expected bladder capacity; FBC in chart, functional bladder capacity in 48-hour frequency/volume chart; FBC in UFM, FBC in uroflowmetry with post-void residual volume.